Antibodies and related products are the fastest growing class of therapeutic agents. By analysing the regulatory approvals of IgG-based biotherapeutic agents in the past 10 years, we can gain ...

Journal of Nuclear Medicine February 2025, jnumed.124.268387; DOI: https://doi.org/10.2967/jnumed.124.268387 ...

Natural human monoclonal antibodies obtained from sentinel lymph nodes of cancer patients identify cell surface vimentin. One of these vimentin-reactive antibodies, pritumumab, has been used to treat ...

The global cancer biologics market size was US$ 110.92 billion in 2024 and is expected to reach US$ 215.60 billion by 2033, expanding at a compound annual growth rate (CAGR) of 7.66% between 2024 and ...